1. Home
  2. XAIR vs BNGO Comparison

XAIR vs BNGO Comparison

Compare XAIR & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$1.01

Market Cap

11.4M

Sector

Health Care

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.14

Market Cap

11.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
XAIR
BNGO
Founded
2011
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.4M
11.6M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
XAIR
BNGO
Price
$1.01
$1.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$11.00
$6.33
AVG Volume (30 Days)
335.3K
229.9K
Earning Date
05-24-2026
03-28-2026
Dividend Yield
N/A
N/A
EPS Growth
62.09
N/A
EPS
N/A
N/A
Revenue
$3,705,000.00
$12,000,735.00
Revenue This Year
$126.42
N/A
Revenue Next Year
$130.48
$24.27
P/E Ratio
N/A
N/A
Revenue Growth
219.67
26.26
52 Week Low
$0.15
$1.06
52 Week High
$3.78
$5.50

Technical Indicators

Market Signals
Indicator
XAIR
BNGO
Relative Strength Index (RSI) 44.66 33.38
Support Level $1.02 $1.08
Resistance Level $1.16 $1.23
Average True Range (ATR) 0.11 0.08
MACD -0.01 0.00
Stochastic Oscillator 43.15 27.59

Price Performance

Historical Comparison
XAIR
BNGO

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: